Hudson Bay Capital Management

Hudson Bay Capital Management Portfolio holdings

AUM $16.4B
1-Year Est. Return 15.5%
This Quarter Est. Return
1 Year Est. Return
+15.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
+$1.23B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,353
New
Increased
Reduced
Closed

Top Buys

1
+$505M
2
+$239M
3
+$230M
4
TSM icon
TSMC
TSM
+$185M
5
SPY icon
SPDR S&P 500 ETF Trust
SPY
+$170M

Top Sells

1
+$284M
2
+$236M
3
+$206M
4
NVDA icon
NVIDIA
NVDA
+$199M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$165M

Sector Composition

1 Technology 19.45%
2 Consumer Discretionary 16.47%
3 Financials 12.6%
4 Healthcare 7.25%
5 Real Estate 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCGA
601
Yorkville Acquisition Corp
MCGA
$239M
$1.6M 0.01%
+150,000
HNRG icon
602
Hallador Energy
HNRG
$930M
$1.56M 0.01%
79,549
-10,554
IPEX
603
Inflection Point Acquisition Corp. V Class A Ordinary Shares
IPEX
$122M
$1.54M 0.01%
150,000
-150,000
IR icon
604
Ingersoll Rand
IR
$32.3B
$1.53M 0.01%
+18,553
SLNO icon
605
Soleno Therapeutics
SLNO
$2.79B
$1.51M 0.01%
22,362
-44,990
ACAD icon
606
Acadia Pharmaceuticals
ACAD
$4.59B
$1.5M 0.01%
70,300
-119,700
AXIN
607
Axiom Intelligence Acquisition Corp 1
AXIN
$275M
$1.5M 0.01%
+150,000
GTERA
608
Globa Terra Acquisition Corp
GTERA
$235M
$1.5M 0.01%
+150,000
RDAG
609
Republic Digital Acquisition Co
RDAG
$383M
$1.5M 0.01%
146,580
XLK icon
610
State Street Technology Select Sector SPDR ETF
XLK
$92.1B
$1.49M 0.01%
+10,600
IMVT icon
611
Immunovant
IMVT
$5.24B
$1.49M 0.01%
92,500
MBX
612
MBX Biosciences
MBX
$1.27B
$1.49M ﹤0.01%
+85,000
APAD
613
A Paradise Acquisition Corp
APAD
$274M
$1.49M ﹤0.01%
+150,000
OTIS icon
614
Otis Worldwide
OTIS
$34.3B
$1.46M ﹤0.01%
15,920
-20,169
MRNA icon
615
Moderna
MRNA
$11.7B
$1.42M ﹤0.01%
55,000
-20,000
STLD icon
616
Steel Dynamics
STLD
$24.7B
$1.41M ﹤0.01%
10,089
-19,966
ITT icon
617
ITT
ITT
$15B
$1.37M ﹤0.01%
7,665
-17,773
GILD icon
618
Gilead Sciences
GILD
$149B
$1.33M ﹤0.01%
12,014
-12,411
CHRS icon
619
Coherus Oncology
CHRS
$168M
$1.33M ﹤0.01%
810,000
-25,000
DXLG icon
620
Destination XL Group
DXLG
$62.3M
$1.31M ﹤0.01%
1,000,004
KYMR icon
621
Kymera Therapeutics
KYMR
$7.17B
$1.31M ﹤0.01%
23,134
+18,134
MTRX icon
622
Matrix Service
MTRX
$343M
$1.31M ﹤0.01%
+100,000
RNA icon
623
Avidity Biosciences
RNA
$10.8B
$1.31M ﹤0.01%
30,000
-45,000
LRMR icon
624
Larimar Therapeutics
LRMR
$347M
$1.3M ﹤0.01%
403,449
+174,688
NUVL icon
625
Nuvalent
NUVL
$8.15B
$1.3M ﹤0.01%
+15,000
23 24
25
26 27